Literature DB >> 25122794

The VP4 peptide of hepatitis A virus ruptures membranes through formation of discrete pores.

Ashutosh Shukla1, Aditya K Padhi1, James Gomes1, Manidipa Banerjee2.   

Abstract

UNLABELLED: Membrane-active peptides, components of capsid structural proteins, assist viruses in overcoming the host membrane barrier in the initial stages of infection. Several such peptides have been identified, and their roles in membrane fusion or disruption have been characterized through biophysical studies. In several members of the Picornaviridae family, the role of the VP4 structural peptide in cellular-membrane penetration is well established. However, there is not much information on the membrane-penetrating capsid components of hepatitis A virus (HAV), an unusual member of this family. The VP4 peptide of HAV differs from its analogues in other picornaviruses in being significantly shorter in length and in lacking a signal for myristoylation, thought to be a critical requisite for VP4-mediated membrane penetration. Here we report, for the first time, that the atypical VP4 in HAV contains significant membrane-penetrating activity. Using a combination of biophysical assays and molecular dynamics simulation studies, we show that VP4 integrates into membrane vesicles through its N-terminal region to finally form discrete pores of 5- to 9-nm diameter, which induces leakage in the vesicles without altering their overall size or shape. We further demonstrate that the membrane activity of VP4 is specific toward vesicles mimicking the lipid content of late endosomes at acidic pH. Taken together, our data indicate that VP4 might be essential for the penetration of host endosomal membranes and release of the viral genome during HAV entry. IMPORTANCE: Hepatitis A virus causes acute hepatitis in humans through the fecal-oral route and is particularly prevalent in underdeveloped regions with poor hygienic conditions. Although a vaccine for HAV exists, its high cost makes it unsuitable for universal application in developing countries. Studies on host-virus interaction for HAV have been hampered due to a lack of starting material, since the virus is extremely slow growing in culture. Among the unknown aspects of the HAV life cycle is its manner of host membrane penetration, which is one of the most important initial steps in viral infection. Here, we present data to suggest that a small peptide, VP4, a component of the HAV structural polyprotein, might be essential in helping the viral genome cross cell membranes during entry. It is hoped that this work might help in elucidating the manner of initial host cell interaction by HAV.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25122794      PMCID: PMC4248947          DOI: 10.1128/JVI.01896-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Alteration of hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobin-and mucin-like regions.

Authors:  Erica Silberstein; Li Xing; Willem van de Beek; Jinhua Lu; Holland Cheng; Gerardo G Kaplan
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 2.  Hepatitis A virus: from discovery to vaccines.

Authors:  Annette Martin; Stanley M Lemon
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

3.  Mammalian reovirus, a nonfusogenic nonenveloped virus, forms size-selective pores in a model membrane.

Authors:  Melina A Agosto; Tijana Ivanovic; Max L Nibert
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

Review 4.  Epidemiological transition of hepatitis A in India: issues for vaccination in developing countries.

Authors:  P Mathur; N K Arora
Journal:  Indian J Med Res       Date:  2008-12       Impact factor: 2.375

5.  Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles.

Authors:  D Marc; G Masson; M Girard; S van der Werf
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

6.  GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit.

Authors:  Sander Pronk; Szilárd Páll; Roland Schulz; Per Larsson; Pär Bjelkmar; Rossen Apostolov; Michael R Shirts; Jeremy C Smith; Peter M Kasson; David van der Spoel; Berk Hess; Erik Lindahl
Journal:  Bioinformatics       Date:  2013-02-13       Impact factor: 6.937

7.  Capturing native/native like structures with a physico-chemical metric (pcSM) in protein folding.

Authors:  Avinash Mishra; Satyanarayan Rao; Aditya Mittal; B Jayaram
Journal:  Biochim Biophys Acta       Date:  2013-05-07

Review 8.  Flock house virus: a model system for understanding non-enveloped virus entry and membrane penetration.

Authors:  Amy Odegard; Manidipa Banerjee; John E Johnson
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

9.  Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles.

Authors:  Robert B Best; Xiao Zhu; Jihyun Shim; Pedro E M Lopes; Jeetain Mittal; Michael Feig; Alexander D Mackerell
Journal:  J Chem Theory Comput       Date:  2012-07-18       Impact factor: 6.006

10.  The interaction of hepatitis A virus (HAV) with soluble forms of its cellular receptor 1 (HAVCR1) share the physiological requirements of infectivity in cell culture.

Authors:  Erica Silberstein; Krishnamurthy Konduru; Gerardo G Kaplan
Journal:  Virol J       Date:  2009-10-27       Impact factor: 4.099

View more
  16 in total

1.  The bacteriophage ϕ29 tail possesses a pore-forming loop for cell membrane penetration.

Authors:  Jingwei Xu; Miao Gui; Dianhong Wang; Ye Xiang
Journal:  Nature       Date:  2016-06-15       Impact factor: 49.962

Review 2.  Hepatitis A Virus Genome Organization and Replication Strategy.

Authors:  Kevin L McKnight; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2018-12-03       Impact factor: 6.915

3.  Emerging Diversity in Lipid-Protein Interactions.

Authors:  Valentina Corradi; Besian I Sejdiu; Haydee Mesa-Galloso; Haleh Abdizadeh; Sergei Yu Noskov; Siewert J Marrink; D Peter Tieleman
Journal:  Chem Rev       Date:  2019-02-13       Impact factor: 60.622

Review 4.  Lipid Tales of Viral Replication and Transmission.

Authors:  Nihal Altan-Bonnet
Journal:  Trends Cell Biol       Date:  2016-11-09       Impact factor: 20.808

5.  Cryo-EM study of slow bee paralysis virus at low pH reveals iflavirus genome release mechanism.

Authors:  Sergei Kalynych; Tibor Füzik; Antonín Přidal; Joachim de Miranda; Pavel Plevka
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-04       Impact factor: 11.205

Review 6.  Hepatitis A Virus Capsid Structure.

Authors:  David I Stuart; Jingshan Ren; Xiangxi Wang; Zihe Rao; Elizabeth E Fry
Journal:  Cold Spring Harb Perspect Med       Date:  2019-05-01       Impact factor: 6.915

7.  The C-terminal region of the non-structural protein 2B from Hepatitis A Virus demonstrates lipid-specific viroporin-like activity.

Authors:  Ashutosh Shukla; Debajit Dey; Kamalika Banerjee; Anshu Nain; Manidipa Banerjee
Journal:  Sci Rep       Date:  2015-10-30       Impact factor: 4.379

Review 8.  Inhibitor-Based Therapeutics for Treatment of Viral Hepatitis.

Authors:  Debajit Dey; Manidipa Banerjee
Journal:  J Clin Transl Hepatol       Date:  2016-09-25

9.  Cryo-electron Microscopy Study of the Genome Release of the Dicistrovirus Israeli Acute Bee Paralysis Virus.

Authors:  Edukondalu Mullapudi; Tibor Füzik; Antonín Přidal; Pavel Plevka
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

10.  Chimeric O1K foot-and-mouth disease virus with SAT2 outer capsid as an FMD vaccine candidate.

Authors:  Abhay Kotecha; Eva Perez-Martin; Yongjie Harvey; Fuquan Zhang; Serban L Ilca; Elizabeth E Fry; Ben Jackson; Francois Maree; Katherine Scott; Corey W Hecksel; Michiel M Harmsen; Valérie Mioulet; Britta Wood; Nick Juleff; David I Stuart; Bryan Charleston; Julian Seago
Journal:  Sci Rep       Date:  2018-09-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.